Screening of Duchenne Muscular Dystrophy (DMD) Mutations and Investigating Its Mutational Mechanism in Chinese Patients | PLOS ONE
![EMQN best practice guidelines for genetic testing in dystrophinopathies | European Journal of Human Genetics EMQN best practice guidelines for genetic testing in dystrophinopathies | European Journal of Human Genetics](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41431-020-0643-7/MediaObjects/41431_2020_643_Fig1_HTML.png)
EMQN best practice guidelines for genetic testing in dystrophinopathies | European Journal of Human Genetics
![Global epidemiology of Duchenne muscular dystrophy: an updated systematic review and meta-analysis | Orphanet Journal of Rare Diseases | Full Text Global epidemiology of Duchenne muscular dystrophy: an updated systematic review and meta-analysis | Orphanet Journal of Rare Diseases | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13023-020-01430-8/MediaObjects/13023_2020_1430_Fig6_HTML.png)
Global epidemiology of Duchenne muscular dystrophy: an updated systematic review and meta-analysis | Orphanet Journal of Rare Diseases | Full Text
![An Alzheimer's Disease Genetic Risk Score Predicts Longitudinal Thinning of Hippocampal Complex Subregions in Healthy Older Adults | eNeuro An Alzheimer's Disease Genetic Risk Score Predicts Longitudinal Thinning of Hippocampal Complex Subregions in Healthy Older Adults | eNeuro](https://www.eneuro.org/content/eneuro/3/3/ENEURO.0098-16.2016/F1.large.jpg)
An Alzheimer's Disease Genetic Risk Score Predicts Longitudinal Thinning of Hippocampal Complex Subregions in Healthy Older Adults | eNeuro
![Report on the workshop: Meaningful outcome measures for Duchenne muscular dystrophy, London, UK, 30–31 January 2017 - Neuromuscular Disorders Report on the workshop: Meaningful outcome measures for Duchenne muscular dystrophy, London, UK, 30–31 January 2017 - Neuromuscular Disorders](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/3d8136a3-c898-4470-89ab-456445a8304a/gr1_lrg.jpg)
Report on the workshop: Meaningful outcome measures for Duchenne muscular dystrophy, London, UK, 30–31 January 2017 - Neuromuscular Disorders
![Evidence-Based Consensus and Systematic Review on Reducing the Time to Diagnosis of Duchenne Muscular Dystrophy - The Journal of Pediatrics Evidence-Based Consensus and Systematic Review on Reducing the Time to Diagnosis of Duchenne Muscular Dystrophy - The Journal of Pediatrics](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/997d0abf-af1a-4520-b1c6-74e52f188e01/ympd10378-fig-0003_lrg.jpg)
Evidence-Based Consensus and Systematic Review on Reducing the Time to Diagnosis of Duchenne Muscular Dystrophy - The Journal of Pediatrics
![JCI Insight - Duchenne muscular dystrophy hiPSC–derived myoblast drug screen identifies compounds that ameliorate disease in mdx mice JCI Insight - Duchenne muscular dystrophy hiPSC–derived myoblast drug screen identifies compounds that ameliorate disease in mdx mice](https://df6sxcketz7bb.cloudfront.net/manuscripts/134000/134287/medium/jci.insight.134287.ga.jpg)